[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:vasomotor-symptoms":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":41,"states":42},"Vasomotor Symptoms",5,3,[8,16,22,28,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06917313","FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy",[12],"Phase 2","RECRUITING","2026-08-26T02:17:19.710918Z","2026-07-05T05:32:16.702580Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07042516","Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).",[12],"2026-08-26T02:15:56.561131Z","2026-05-05T02:43:27.042730Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07238478","JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women",[],"2026-08-26T02:15:00.557154Z","2026-05-05T02:35:31.933574Z",{"nct_id":29,"title":30,"phases":31,"status":32,"updated_at":33,"content_modified":34},"NCT07490431","An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States",[],"NOT_YET_RECRUITING","2026-08-26T02:18:32.765187Z","2026-05-13T02:55:06.709282Z",{"nct_id":36,"title":37,"phases":38,"status":32,"updated_at":39,"content_modified":40},"NCT07660315","Goji Berry and Vasomotor Symptoms Pilot Study",[],"2026-08-26T02:19:26.493949Z","2026-07-05T03:45:20.258787Z",[],[]]